Conmed (CNMD) Revenue (2010 - 2026)

Conmed has reported Revenue for 17 years, with the latest figure at $317.0 million in Q1 2026.

• For the quarter ending Q1 2026, Revenue fell 1.31% year-over-year to $317.0 million; the trailing twelve-month figure through Mar 2026 stood at $1.4 billion (up 4.14% YoY), and the FY2025 full-year result was $1.4 billion, up 5.18% from the prior year.
• Revenue for Q1 2026 stood at $317.0 million, down from $373.2 million in the prior quarter.
• The five-year high for Revenue was $373.2 million in Q4 2025, with the low at $242.3 million in Q1 2022.
• Historically, Revenue has averaged $311.1 million across 5 years, with a median of $317.0 million in 2026.
• Annual changes were most pronounced in 2022 — Revenue slipped 8.43% — and 2023, when it soared 30.37%.
• Conmed's Revenue stood at $250.9 million in 2022, then surged by 30.37% to $327.0 million in 2023, then advanced by 5.78% to $345.9 million in 2024, then increased by 7.88% to $373.2 million in 2025, then decreased by 15.05% to $317.0 million in 2026.
• The last three Revenue figures came in at $317.0 million (Q1 2026), $373.2 million (Q4 2025), and $337.9 million (Q3 2025), per Business Quant data.